Tissue factor pathway inhibitor: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
WikiBot (talk | contribs)
Bots, Bureaucrats, bureaucrats, interwiki, nocaptcha, Administrators
57,550 edits
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)
 
imported>Bibcode Bot
m Adding 0 arxiv eprint(s), 1 bibcode(s) and 0 doi(s). Did it miss something? Report bugs, errors, and suggestions at User talk:Bibcode Bot
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
{{PBB_Controls
{{Infobox_gene}}
| update_page = yes
'''Tissue factor pathway inhibitor''' (or '''TFPI''') is a single-chain polypeptide which can reversibly inhibit [[Factor Xa]] (Xa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the [[Factor VII|FVIIa]]-[[tissue factor]] complex.
| require_manual_inspection = no
TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5 nM.
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}
{{GNF_Protein_box
| image = PBB_Protein_TFPI_image.jpg
| image_source = [[Protein_Data_Bank|PDB]] rendering based on 1adz.
| Name = Tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
| HGNCid = 11760
| Symbol = TFPI
| AltSymbols =; TFI; EPI; LACI
| OMIM = 152310
| ECnumber = 
| Homologene = 4579
| MGIid = 1095418
| GeneAtlas_image1 = PBB_GE_TFPI_209676_at_tn.png
| GeneAtlas_image2 = PBB_GE_TFPI_210664_s_at_tn.png
| GeneAtlas_image3 = PBB_GE_TFPI_210665_at_tn.png
| Function = {{GNF_GO|id=GO:0004867 |text = serine-type endopeptidase inhibitor activity}} {{GNF_GO|id=GO:0030414 |text = protease inhibitor activity}}
| Component = {{GNF_GO|id=GO:0005576 |text = extracellular region}}
| Process = {{GNF_GO|id=GO:0007596 |text = blood coagulation}}
| Orthologs = {{GNF_Ortholog_box
    | Hs_EntrezGene = 7035
    | Hs_Ensembl = ENSG00000003436
    | Hs_RefseqProtein = NP_001027452
    | Hs_RefseqmRNA = NM_001032281
    | Hs_GenLoc_db = 
    | Hs_GenLoc_chr = 2
    | Hs_GenLoc_start = 188039530
    | Hs_GenLoc_end = 188127410
    | Hs_Uniprot = P10646
    | Mm_EntrezGene = 21788
    | Mm_Ensembl = ENSMUSG00000027082
    | Mm_RefseqmRNA = NM_011576
    | Mm_RefseqProtein = NP_035706
    | Mm_GenLoc_db = 
    | Mm_GenLoc_chr = 2
    | Mm_GenLoc_start = 84233699
    | Mm_GenLoc_end = 84275013
    | Mm_Uniprot = O54819
  }}
}}
{{SI}}
{{CMG}}


==Genetics==
The gene for TFPI is located on chromosome 2q31-q32.1, and has nine exons which span 70 kb. The gene has not been completely sequenced yet. A similar gene, termed ''TFPI2'', has been identified on chromosome 7q22; in addition to TFPI activity, its product also has retinal pigment epithelial cell growth-promoting properties.


==Protein structure==
TFPI has a relative molecular mass of 34,000 to 40,000 depending on the degree of proteolysis of the C-terminal region.


'''Tissue factor pathway inhibitor''' (or '''TFPI''') is a single-chain polypeptide which can reversibly inhibit [[Factor X]]a (Xa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the [[Factor VII|FVIIa]]-[[tissue factor|TF]] complex.
TFPI consists of a highly negatively charged amino-terminus, three tandemly linked [[Kunitz domain]]s, and a highly positively charged carboxy-terminus. With its Kunitz domains, TFPI exhibits significant homology with human [[inter-alpha-trypsin inhibitor]] and bovine [[basic pancreatic trypsin inhibitor]].
TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5nM.


==Genetics==
==Interactions==
The gene for TFPI is located on chromosome 2q31-q32.1, and has nine exons which span 70kb. The gene has not been completely sequenced yet. A similar gene, termed ''TFPI2'', has been identified on chromosome 7q22; in addition to TFPI activity, its product also has retinal pigment epithelial cell growth-promoting properties.
Tissue factor pathway inhibitor has been shown to [[Protein-protein interaction|interact]] with [[Factor X]].<ref name=pmid3422166>{{cite journal |last=Broze |first=G J |authorlink= |author2=Warren L A |author3=Novotny W F |author4=Higuchi D A |author5=Girard J J |author6=Miletich J P  |date=Feb 1988 |title=The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action |journal=Blood |volume=71 |issue=2 |pages=335–43 |publisher= |location = UNITED STATES| issn = 0006-4971| pmid = 3422166 | bibcode = | oclc =| id = | url = | language = | format = | accessdate = | laysummary = | laysource = | laydate = | quote = }}</ref>


==Protein structure==
==See also==
TFPI has a relative molecular mass of 34000 to 40000 depending on the degree of proteolysis of the C-terminal region.
* [[Hemostasis]]


==See also==
==References==
* [[hemostasis]]
{{reflist}}


==External links==
==External links==
* {{OMIM|152310}} (''TFPI1''), {{OMIM|600033}} (''TFPI2'')
* {{OMIM|152310}} (''TFPI1''), {{OMIM|600033}} (''TFPI2'')


==References==
{{reflist}}
==Further reading==
==Further reading==
{{refbegin | 2}}
{{refbegin | 2}}
{{PBB_Further_reading  
{{PBB_Further_reading  
| citations =  
| citations =  
*{{cite journal  | author=Broze GJ, Girard TJ, Novotny WF |title=Regulation of coagulation by a multivalent Kunitz-type inhibitor. |journal=Biochemistry |volume=29 |issue= 33 |pages= 7539-46 |year= 1991 |pmid= 2271516 |doi=  }}
*{{cite journal  |vauthors=Broze GJ, Girard TJ, Novotny WF |title=Regulation of coagulation by a multivalent Kunitz-type inhibitor. |journal=Biochemistry |volume=29 |issue= 33 |pages= 7539–46 |year= 1991 |pmid= 2271516 |doi=10.1021/bi00485a001 }}
*{{cite journal  | author=McVey JH |title=Tissue factor pathway. |journal=Baillieres Best Pract. Res. Clin. Haematol. |volume=12 |issue= 3 |pages= 361-72 |year= 2000 |pmid= 10856975 |doi=  }}
*{{cite journal  | author=McVey JH |title=Tissue factor pathway. |journal=Best Practice & Research. Clinical Haematology |volume=12 |issue= 3 |pages= 361–72 |year= 2000 |pmid= 10856975 |doi=  10.1053/beha.1999.0030}}
*{{cite journal  | author=Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP |title=Structure and biology of tissue factor pathway inhibitor. |journal=Thromb. Haemost. |volume=86 |issue= 4 |pages= 959-72 |year= 2002 |pmid= 11686353 |doi=  }}
*{{cite journal  |vauthors=Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP |title=Structure and biology of tissue factor pathway inhibitor. |journal=Thromb. Haemost. |volume=86 |issue= 4 |pages= 959–72 |year= 2002 |pmid= 11686353 |doi=  }}
*{{cite journal  | author=Witt I |title=[Tissue factor pathway inhibitor: biochemistry, molecular biology, physiology and physiopathology] |journal=Hamostaseologie |volume=22 |issue= 2 |pages= 30-5 |year= 2002 |pmid= 12193974 |doi= 10.1267/Hamo02020071 }}
*{{cite journal  | author=Witt I |title=[Tissue factor pathway inhibitor: biochemistry, molecular biology, physiology and physiopathology] |journal=Hamostaseologie |volume=22 |issue= 2 |pages= 30–5 |year= 2002 |pmid= 12193974 |doi=10.1267/Hamo02020071}}
*{{cite journal  | author=Lwaleed BA, Bass PS |title=Tissue factor pathway inhibitor: structure, biology and involvement in disease. |journal=J. Pathol. |volume=208 |issue= 3 |pages= 327-39 |year= 2006 |pmid= 16261634 |doi= 10.1002/path.1871 }}
*{{cite journal  |vauthors=Lwaleed BA, Bass PS |title=Tissue factor pathway inhibitor: structure, biology and involvement in disease. |journal=J. Pathol. |volume=208 |issue= 3 |pages= 327–39 |year= 2006 |pmid= 16261634 |doi= 10.1002/path.1871 }}
*{{cite journal | author=Van der Logt CP, Kluck PM, Wiegant J, ''et al.'' |title=Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridization. |journal=Hum. Genet. |volume=89 |issue= 5 |pages= 577-8 |year= 1992 |pmid= 1353057 |doi=  }}
*{{cite journal   |vauthors=Van der Logt CP, Kluck PM, Wiegant J, etal |title=Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridization. |journal=Hum. Genet. |volume=89 |issue= 5 |pages= 577–8 |year= 1992 |pmid= 1353057 |doi=  10.1007/bf00219189}}
*{{cite journal  | author=Higuchi DA, Wun TC, Likert KM, Broze GJ |title=The effect of leukocyte elastase on tissue factor pathway inhibitor. |journal=Blood |volume=79 |issue= 7 |pages= 1712-9 |year= 1992 |pmid= 1558967 |doi=  }}
*{{cite journal  |vauthors=Higuchi DA, Wun TC, Likert KM, Broze GJ |title=The effect of leukocyte elastase on tissue factor pathway inhibitor. |journal=Blood |volume=79 |issue= 7 |pages= 1712–9 |year= 1992 |pmid= 1558967 |doi=  }}
*{{cite journal  | author=van der Logt CP, Reitsma PH, Bertina RM |title=Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation. |journal=Biochemistry |volume=30 |issue= 6 |pages= 1571-7 |year= 1991 |pmid= 1993173 |doi=  }}
*{{cite journal  |vauthors=van der Logt CP, Reitsma PH, Bertina RM |title=Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation. |journal=Biochemistry |volume=30 |issue= 6 |pages= 1571–7 |year= 1991 |pmid= 1993173 |doi=10.1021/bi00220a018 }}
*{{cite journal | author=Girard TJ, Eddy R, Wesselschmidt RL, ''et al.'' |title=Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2. |journal=J. Biol. Chem. |volume=266 |issue= 8 |pages= 5036-41 |year= 1991 |pmid= 2002045 |doi=  }}
*{{cite journal   |vauthors=Girard TJ, Eddy R, Wesselschmidt RL, etal |title=Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2. |journal=J. Biol. Chem. |volume=266 |issue= 8 |pages= 5036–41 |year= 1991 |pmid= 2002045 |doi=  }}
*{{cite journal | author=Wun TC, Kretzmer KK, Girard TJ, ''et al.'' |title=Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. |journal=J. Biol. Chem. |volume=263 |issue= 13 |pages= 6001-4 |year= 1988 |pmid= 2452157 |doi=  }}
*{{cite journal   |vauthors=Wun TC, Kretzmer KK, Girard TJ, etal |title=Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains. |journal=J. Biol. Chem. |volume=263 |issue= 13 |pages= 6001–4 |year= 1988 |pmid= 2452157 |doi=  }}
*{{cite journal  | author=Novotny WF, Girard TJ, Miletich JP, Broze GJ |title=Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. |journal=J. Biol. Chem. |volume=264 |issue= 31 |pages= 18832-7 |year= 1989 |pmid= 2553722 |doi=  }}
*{{cite journal  |vauthors=Novotny WF, Girard TJ, Miletich JP, Broze GJ |title=Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma. |journal=J. Biol. Chem. |volume=264 |issue= 31 |pages= 18832–7 |year= 1989 |pmid= 2553722 |doi=  }}
*{{cite journal | author=Girard TJ, Warren LA, Novotny WF, ''et al.'' |title=Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. |journal=Thromb. Res. |volume=55 |issue= 1 |pages= 37-50 |year= 1989 |pmid= 2781520 |doi=  }}
*{{cite journal   |vauthors=Girard TJ, Warren LA, Novotny WF, etal |title=Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein. |journal=Thromb. Res. |volume=55 |issue= 1 |pages= 37–50 |year= 1989 |pmid= 2781520 |doi=10.1016/0049-3848(89)90454-4 }}
*{{cite journal | author=Girard TJ, Warren LA, Novotny WF, ''et al.'' |title=Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. |journal=Nature |volume=338 |issue= 6215 |pages= 518-20 |year= 1989 |pmid= 2927510 |doi= 10.1038/338518a0 }}
*{{cite journal   |vauthors=Girard TJ, Warren LA, Novotny WF, etal |title=Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor. |journal=Nature |volume=338 |issue= 6215 |pages= 518–20 |year= 1989 |pmid= 2927510 |doi= 10.1038/338518a0 |bibcode=1989Natur.338..518G }}
*{{cite journal  | author=Broze GJ, Miletich JP |title=Characterization of the inhibition of tissue factor in serum. |journal=Blood |volume=69 |issue= 1 |pages= 150-5 |year= 1987 |pmid= 3024756 |doi=  }}
*{{cite journal  |vauthors=Broze GJ, Miletich JP |title=Characterization of the inhibition of tissue factor in serum. |journal=Blood |volume=69 |issue= 1 |pages= 150–5 |year= 1987 |pmid= 3024756 |doi=  }}
*{{cite journal | author=Broze GJ, Warren LA, Novotny WF, ''et al.'' |title=The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. |journal=Blood |volume=71 |issue= 2 |pages= 335-43 |year= 1988 |pmid= 3422166 |doi=  }}
*{{cite journal   |vauthors=Broze GJ, Warren LA, Novotny WF, etal |title=The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. |journal=Blood |volume=71 |issue= 2 |pages= 335–43 |year= 1988 |pmid= 3422166 |doi=  }}
*{{cite journal  | author=Rao LV, Rapaport SI |title=Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. |journal=Blood |volume=69 |issue= 2 |pages= 645-51 |year= 1987 |pmid= 3492226 |doi=  }}
*{{cite journal  |vauthors=Rao LV, Rapaport SI |title=Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. |journal=Blood |volume=69 |issue= 2 |pages= 645–51 |year= 1987 |pmid= 3492226 |doi=  }}
*{{cite journal  | author=Stubbs MT, Huber R, Bode W |title=Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin. |journal=FEBS Lett. |volume=375 |issue= 1-2 |pages= 103-7 |year= 1996 |pmid= 7498454 |doi=  }}
*{{cite journal  |vauthors=Stubbs MT, Huber R, Bode W |title=Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin. |journal=FEBS Lett. |volume=375 |issue= 1-2 |pages= 103–7 |year= 1996 |pmid= 7498454 |doi=10.1016/0014-5793(95)01190-P }}
*{{cite journal | author=Warshawsky I, Bu G, Mast A, ''et al.'' |title=The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo. |journal=J. Clin. Invest. |volume=95 |issue= 4 |pages= 1773-81 |year= 1995 |pmid= 7706485 |doi=  }}
*{{cite journal   |vauthors=Warshawsky I, Bu G, Mast A, etal |title=The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo. |journal=J. Clin. Invest. |volume=95 |issue= 4 |pages= 1773–81 |year= 1995 |pmid= 7706485 |doi=10.1172/JCI117855  | pmc=295702 }}
*{{cite journal  | author=Broze GJ, Lange GW, Duffin KL, MacPhail L |title=Heterogeneity of plasma tissue factor pathway inhibitor. |journal=Blood Coagul. Fibrinolysis |volume=5 |issue= 4 |pages= 551-9 |year= 1995 |pmid= 7841311 |doi=  }}
*{{cite journal  |vauthors=Broze GJ, Lange GW, Duffin KL, MacPhail L |title=Heterogeneity of plasma tissue factor pathway inhibitor. |journal=Blood Coagul. Fibrinolysis |volume=5 |issue= 4 |pages= 551–9 |year= 1995 |pmid= 7841311 |doi=  }}
}}
}}
{{refend}}
{{refend}}
{{PDB Gallery|geneid=7035}}


{{Coagulation}}
{{Coagulation}}
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. -->
{{PBB_Controls
| update_page = yes
| require_manual_inspection = no
| update_protein_box = yes
| update_summary = no
| update_citations = yes
}}


[[Category:Coagulation system]]
[[Category:Coagulation system]]
[[Category:Hematology]]


{{WikiDoc Help Menu}}
 
{{WikiDoc Sources}}
{{molecular-cell-biology-stub}}

Latest revision as of 21:29, 26 June 2018

VALUE_ERROR (nil)
Identifiers
Aliases
External IDsGeneCards: [1]
Orthologs
SpeciesHumanMouse
Entrez

n/a

n/a

Ensembl

n/a

n/a

UniProt

n/a

n/a

RefSeq (mRNA)

n/a

n/a

RefSeq (protein)

n/a

n/a

Location (UCSC)n/an/a
PubMed searchn/an/a
Wikidata
View/Edit Human

Tissue factor pathway inhibitor (or TFPI) is a single-chain polypeptide which can reversibly inhibit Factor Xa (Xa). While Xa is inhibited, the Xa-TFPI complex can subsequently also inhibit the FVIIa-tissue factor complex. TFPI contributes significantly to the inhibition of Xa in vivo, despite being present at concentrations of only 2.5 nM.

Genetics

The gene for TFPI is located on chromosome 2q31-q32.1, and has nine exons which span 70 kb. The gene has not been completely sequenced yet. A similar gene, termed TFPI2, has been identified on chromosome 7q22; in addition to TFPI activity, its product also has retinal pigment epithelial cell growth-promoting properties.

Protein structure

TFPI has a relative molecular mass of 34,000 to 40,000 depending on the degree of proteolysis of the C-terminal region.

TFPI consists of a highly negatively charged amino-terminus, three tandemly linked Kunitz domains, and a highly positively charged carboxy-terminus. With its Kunitz domains, TFPI exhibits significant homology with human inter-alpha-trypsin inhibitor and bovine basic pancreatic trypsin inhibitor.

Interactions

Tissue factor pathway inhibitor has been shown to interact with Factor X.[1]

See also

References

  1. ↑ Broze, G J; Warren L A; Novotny W F; Higuchi D A; Girard J J; Miletich J P (Feb 1988). "The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action". Blood. UNITED STATES. 71 (2): 335–43. ISSN 0006-4971. PMID 3422166.

External links

Further reading

  • Broze GJ, Girard TJ, Novotny WF (1991). "Regulation of coagulation by a multivalent Kunitz-type inhibitor". Biochemistry. 29 (33): 7539–46. doi:10.1021/bi00485a001. PMID 2271516.
  • McVey JH (2000). "Tissue factor pathway". Best Practice & Research. Clinical Haematology. 12 (3): 361–72. doi:10.1053/beha.1999.0030. PMID 10856975.
  • Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP (2002). "Structure and biology of tissue factor pathway inhibitor". Thromb. Haemost. 86 (4): 959–72. PMID 11686353.
  • Witt I (2002). "[Tissue factor pathway inhibitor: biochemistry, molecular biology, physiology and physiopathology]". Hamostaseologie. 22 (2): 30–5. doi:10.1267/Hamo02020071. PMID 12193974.
  • Lwaleed BA, Bass PS (2006). "Tissue factor pathway inhibitor: structure, biology and involvement in disease". J. Pathol. 208 (3): 327–39. doi:10.1002/path.1871. PMID 16261634.
  • Van der Logt CP, Kluck PM, Wiegant J, et al. (1992). "Refined regional assignment of the human tissue factor pathway inhibitor (TFPI) gene to chromosome band 2q32 by non-isotopic in situ hybridization". Hum. Genet. 89 (5): 577–8. doi:10.1007/bf00219189. PMID 1353057.
  • Higuchi DA, Wun TC, Likert KM, Broze GJ (1992). "The effect of leukocyte elastase on tissue factor pathway inhibitor". Blood. 79 (7): 1712–9. PMID 1558967.
  • van der Logt CP, Reitsma PH, Bertina RM (1991). "Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation". Biochemistry. 30 (6): 1571–7. doi:10.1021/bi00220a018. PMID 1993173.
  • Girard TJ, Eddy R, Wesselschmidt RL, et al. (1991). "Structure of the human lipoprotein-associated coagulation inhibitor gene. Intro/exon gene organization and localization of the gene to chromosome 2". J. Biol. Chem. 266 (8): 5036–41. PMID 2002045.
  • Wun TC, Kretzmer KK, Girard TJ, et al. (1988). "Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains". J. Biol. Chem. 263 (13): 6001–4. PMID 2452157.
  • Novotny WF, Girard TJ, Miletich JP, Broze GJ (1989). "Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma". J. Biol. Chem. 264 (31): 18832–7. PMID 2553722.
  • Girard TJ, Warren LA, Novotny WF, et al. (1989). "Identification of the 1.4 kb and 4.0 kb messages for the lipoprotein associated coagulation inhibitor and expression of the encoded protein". Thromb. Res. 55 (1): 37–50. doi:10.1016/0049-3848(89)90454-4. PMID 2781520.
  • Girard TJ, Warren LA, Novotny WF, et al. (1989). "Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor". Nature. 338 (6215): 518–20. Bibcode:1989Natur.338..518G. doi:10.1038/338518a0. PMID 2927510.
  • Broze GJ, Miletich JP (1987). "Characterization of the inhibition of tissue factor in serum". Blood. 69 (1): 150–5. PMID 3024756.
  • Broze GJ, Warren LA, Novotny WF, et al. (1988). "The lipoprotein-associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action". Blood. 71 (2): 335–43. PMID 3422166.
  • Rao LV, Rapaport SI (1987). "Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation". Blood. 69 (2): 645–51. PMID 3492226.
  • Stubbs MT, Huber R, Bode W (1996). "Crystal structures of factor Xa specific inhibitors in complex with trypsin: structural grounds for inhibition of factor Xa and selectivity against thrombin". FEBS Lett. 375 (1–2): 103–7. doi:10.1016/0014-5793(95)01190-P. PMID 7498454.
  • Warshawsky I, Bu G, Mast A, et al. (1995). "The carboxy terminus of tissue factor pathway inhibitor is required for interacting with hepatoma cells in vitro and in vivo". J. Clin. Invest. 95 (4): 1773–81. doi:10.1172/JCI117855. PMC 295702. PMID 7706485.
  • Broze GJ, Lange GW, Duffin KL, MacPhail L (1995). "Heterogeneity of plasma tissue factor pathway inhibitor". Blood Coagul. Fibrinolysis. 5 (4): 551–9. PMID 7841311.


Retrieved from "https://www.wikidoc.org/index.php?title=Tissue_factor_pathway_inhibitor&oldid=1531543"